Halozyme Therapeutics Inc (HALO)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	281,594	202,129	402,710	129,085	-72,240
Revenue	US$ in thousands	809,880	641,313	435,810	267,594	195,992
Net profit margin		34.77%	31.52%	92.40%	48.24%	-36.86%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $281,594K ÷ $809,880K
= 34.77%

Halozyme Therapeutics Inc.'s net profit margin has fluctuated significantly over the past five years, ranging from a negative figure in 2019 to a high of 90.84% in 2021. In 2023, the net profit margin stood at 33.96%, indicating that the company retained approximately 33.96% of its revenue as profit after accounting for all expenses.

The substantial increase in net profit margin from 2019 to 2021 suggests a significant improvement in the company's operational efficiency and cost management during those years. However, it is essential to note the sharp decline in net profit margin in 2022, which might indicate potential challenges or increased costs impacting the company's profitability during that period.

Overall, although the net profit margin has shown volatility over the years, it is currently at a healthy level in 2023, indicating that Halozyme Therapeutics Inc. is effectively managing its costs and generating profits relative to its revenue.